Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,411,552
+$952,317 QoQ
Shares Held
29,453
-0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.20%
of 13F equity value
Holder Rank
#1,071
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. ABBV ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,037 | $775,754 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,411,552 | 29,453 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,459,235 | 29,699 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,856,756 | 30,009 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,062,664 | 30,503 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,657,140 | 30,477 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,056,385 | 28,906 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,311,453 | 29,890 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $6,011,686 | 30,442 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,634,432 | 32,850 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,115,646 | 33,584 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,120,850 | 39,497 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,784,316 | 45,514 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,217,115 | 46,145 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,589,677 | 47,623 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,819,338 | 48,384 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,201,574 | 53,659 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,485,523 | 55,403 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,645,869 | 59,502 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $18,885,727 | 139,481 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,826,184 | 72,552 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,310,579 | 73,780 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $8,228,183 | 76,032 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $8,427,668 | 78,653 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $6,894,822 | 78,717 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $7,727,747 | 78,710 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,281,408 | 82,444 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||